The findings suggest that smoking related biological pathways leading to the development of lung cancer involve not only hypermethylations of p16, DAPK and RARβ promoters but also genetic polymorphisms of CYP1A1 and GSTM1 genes. Here, CYP1A1 is linked to lung cancer.